ROYAL BANK OF CANADA - CORTEXYME INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CORTEXYME INC
ValueSharesWeighting
Q3 2023$0
-100.0%
137
-71.3%
0.00%
Q2 2023$1,000
-75.0%
478
-84.5%
0.00%
Q3 2022$4,000
-20.0%
3,084
+31.1%
0.00%
Q2 2022$5,000
-44.4%
2,353
+73.7%
0.00%
Q1 2022$9,000
-85.2%
1,355
-72.2%
0.00%
Q4 2021$61,000
-62.3%
4,868
+174.9%
0.00%
Q3 2021$162,000
-51.9%
1,771
-72.2%
0.00%
Q2 2021$337,000
+891.2%
6,365
+583.7%
0.00%
Q1 2021$34,000
+750.0%
931
+546.5%
0.00%
Q4 2020$4,000
+300.0%
144
+433.3%
0.00%
Q3 2020$1,0000.0%270.0%0.00%
Q2 2020$1,000
-50.0%
27
-47.1%
0.00%
Q1 2020$2,0000.0%51
-23.9%
0.00%
Q3 2019$2,000670.00%
Other shareholders
CORTEXYME INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,498,868$3,918,7320.55%
EPIQ Capital Group, LLC 926,500$1,037,6800.54%
Intellectus Partners, LLC 53,527$59,9500.02%
Alphabet Inc. 189,122$211,8170.01%
COHEN LAWRENCE B 11,126$12,4610.01%
XTX Topco Ltd 31,940$35,7730.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 138,495$155,1140.00%
Strategic Blueprint, LLC 12,200$13,6640.00%
Renaissance Technologies 325,000$3640.00%
Orion Portfolio Solutions, LLC 10,136$11,3520.00%
View complete list of CORTEXYME INC shareholders